HK Stock MarketDetailed Quotes

09995 REMEGEN

Watchlist
  • 15.540
  • +0.980+6.73%
Market Closed Oct 18 16:08 CST
8.46BMarket Cap-4860P/E (TTM)

REMEGEN Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Turnover
76.50%739.66M
96.41%330.43M
40.16%1.08B
35.08%769.47M
20.15%419.07M
12.06%168.24M
-46.08%767.78M
397.47%569.64M
1,094.78%348.78M
--150.14M
Operating income
76.50%739.66M
96.41%330.43M
40.16%1.08B
35.08%769.47M
20.15%419.07M
12.06%168.24M
-46.08%767.78M
397.47%569.64M
1,094.78%348.78M
150.14M
Cost of sales
-64.89%-169.27M
----
6.22%-253.14M
----
38.72%-102.66M
----
-301.92%-269.94M
----
-3,510.02%-167.51M
----
Operating expenses
-64.89%-169.27M
-196.17%-74.36M
6.22%-253.14M
20.47%-177.8M
38.72%-102.66M
74.25%-25.11M
-301.92%-269.94M
-2,079.96%-223.57M
-3,510.02%-167.51M
-97.51M
Gross profit
80.26%570.39M
78.91%256.08M
65.31%822.99M
70.97%591.67M
74.55%316.42M
171.98%143.13M
-63.31%497.84M
231.95%346.06M
638.33%181.27M
52.63M
Selling expenses
-11.28%-389.67M
-18.81%-187.5M
-75.90%-775.19M
-94.41%-539.79M
-133.51%-350.17M
-95.36%-157.82M
-67.59%-440.7M
-115.68%-277.66M
-146.27%-149.96M
---80.78M
Administrative expenses
7.94%-155.22M
5.70%-74.26M
-15.09%-313.67M
-51.17%-242.87M
-57.70%-168.61M
-60.52%-78.75M
-23.97%-272.54M
-0.86%-160.66M
-8.42%-106.92M
---49.06M
Research and development expenses
-49.18%-806.23M
-32.62%-331.18M
-33.01%-1.31B
-29.50%-857.98M
-20.19%-540.45M
-14.46%-249.72M
-38.13%-982.08M
-26.29%-662.54M
-37.68%-449.67M
---218.17M
Profit from asset sales
----
----
----
----
----
----
----
-3.02%15.5K
----
----
Revaluation surplus
----
-101.81%-49.46K
----
-55.15%5.17M
----
--2.73M
----
--11.53M
----
----
-Changes in the fair value of other assets
----
-101.81%-49.46K
----
-55.15%5.17M
----
--2.73M
----
--11.53M
----
----
Impairment and provision
7.30%-3.81M
-346.42%-4.66M
-1.33%-11.28M
-63.53%-14.92M
26.58%-4.11M
229.03%1.89M
-3,153.80%-11.13M
-1,814.98%-9.12M
-2,386.67%-5.6M
---1.47M
-Other impairment is provision
7.30%-3.81M
-346.42%-4.66M
-1.33%-11.28M
-63.53%-14.92M
26.58%-4.11M
229.03%1.89M
-3,153.80%-11.13M
-1,814.98%-9.12M
-2,386.67%-5.6M
---1.47M
Special items of operating profit
-27.46%35.95M
2.19%11.78M
-55.96%95.35M
32.59%35.44M
12.83%49.56M
55.95%11.53M
82.02%216.54M
43.26%26.73M
117.26%43.92M
--7.39M
Operating profit
-7.35%-748.59M
-1.58%-334.24M
-50.00%-1.49B
-40.94%-1.03B
-43.21%-697.37M
-13.06%-329.03M
-452.32%-992.07M
-5.41%-730.19M
-10.28%-486.95M
-291.02M
Financing cost
-431.38%-31.87M
-256.14%-10.71M
-241.73%-23.09M
-91.90%4.34M
-175.72%-6M
-17.79%6.86M
-26.94%-6.76M
128.81%53.61M
11.94%-2.18M
--8.34M
Share of profits of associates
----
----
---45K
----
----
----
----
----
----
----
Special items of earning before tax
----
-147.00%-3.97M
----
50.34%-5.78M
----
61.33%-1.61M
----
38.68%-11.64M
----
---4.16M
Earning before tax
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
-286.83M
After-tax profit from continuing operations
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
-286.83M
Earning after tax
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
-286.83M
Profit attributable to shareholders
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
-286.83M
Basic earnings per share
-11.54%-1.45
-8.33%-0.65
-48.94%-2.8
-44.70%-1.91
-35.42%-1.3
-1.69%-0.6
-429.82%-1.88
6.38%-1.32
-5.49%-0.96
-0.59
Diluted earnings per share
-11.54%-1.45
-8.33%-0.65
-48.94%-2.8
-44.70%-1.91
-35.42%-1.3
-1.69%-0.6
-429.82%-1.88
6.38%-1.32
-5.49%-0.96
-0.59
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Auditor
--
--
Ernst & Young
--
--
--
Ernst & Young
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Turnover 76.50%739.66M96.41%330.43M40.16%1.08B35.08%769.47M20.15%419.07M12.06%168.24M-46.08%767.78M397.47%569.64M1,094.78%348.78M--150.14M
Operating income 76.50%739.66M96.41%330.43M40.16%1.08B35.08%769.47M20.15%419.07M12.06%168.24M-46.08%767.78M397.47%569.64M1,094.78%348.78M150.14M
Cost of sales -64.89%-169.27M----6.22%-253.14M----38.72%-102.66M-----301.92%-269.94M-----3,510.02%-167.51M----
Operating expenses -64.89%-169.27M-196.17%-74.36M6.22%-253.14M20.47%-177.8M38.72%-102.66M74.25%-25.11M-301.92%-269.94M-2,079.96%-223.57M-3,510.02%-167.51M-97.51M
Gross profit 80.26%570.39M78.91%256.08M65.31%822.99M70.97%591.67M74.55%316.42M171.98%143.13M-63.31%497.84M231.95%346.06M638.33%181.27M52.63M
Selling expenses -11.28%-389.67M-18.81%-187.5M-75.90%-775.19M-94.41%-539.79M-133.51%-350.17M-95.36%-157.82M-67.59%-440.7M-115.68%-277.66M-146.27%-149.96M---80.78M
Administrative expenses 7.94%-155.22M5.70%-74.26M-15.09%-313.67M-51.17%-242.87M-57.70%-168.61M-60.52%-78.75M-23.97%-272.54M-0.86%-160.66M-8.42%-106.92M---49.06M
Research and development expenses -49.18%-806.23M-32.62%-331.18M-33.01%-1.31B-29.50%-857.98M-20.19%-540.45M-14.46%-249.72M-38.13%-982.08M-26.29%-662.54M-37.68%-449.67M---218.17M
Profit from asset sales -----------------------------3.02%15.5K--------
Revaluation surplus -----101.81%-49.46K-----55.15%5.17M------2.73M------11.53M--------
-Changes in the fair value of other assets -----101.81%-49.46K-----55.15%5.17M------2.73M------11.53M--------
Impairment and provision 7.30%-3.81M-346.42%-4.66M-1.33%-11.28M-63.53%-14.92M26.58%-4.11M229.03%1.89M-3,153.80%-11.13M-1,814.98%-9.12M-2,386.67%-5.6M---1.47M
-Other impairment is provision 7.30%-3.81M-346.42%-4.66M-1.33%-11.28M-63.53%-14.92M26.58%-4.11M229.03%1.89M-3,153.80%-11.13M-1,814.98%-9.12M-2,386.67%-5.6M---1.47M
Special items of operating profit -27.46%35.95M2.19%11.78M-55.96%95.35M32.59%35.44M12.83%49.56M55.95%11.53M82.02%216.54M43.26%26.73M117.26%43.92M--7.39M
Operating profit -7.35%-748.59M-1.58%-334.24M-50.00%-1.49B-40.94%-1.03B-43.21%-697.37M-13.06%-329.03M-452.32%-992.07M-5.41%-730.19M-10.28%-486.95M-291.02M
Financing cost -431.38%-31.87M-256.14%-10.71M-241.73%-23.09M-91.90%4.34M-175.72%-6M-17.79%6.86M-26.94%-6.76M128.81%53.61M11.94%-2.18M--8.34M
Share of profits of associates -----------45K----------------------------
Special items of earning before tax -----147.00%-3.97M----50.34%-5.78M----61.33%-1.61M----38.68%-11.64M-------4.16M
Earning before tax -10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M-286.83M
After-tax profit from continuing operations -10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M-286.83M
Earning after tax -10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M-286.83M
Profit attributable to shareholders -10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M-286.83M
Basic earnings per share -11.54%-1.45-8.33%-0.65-48.94%-2.8-44.70%-1.91-35.42%-1.3-1.69%-0.6-429.82%-1.886.38%-1.32-5.49%-0.96-0.59
Diluted earnings per share -11.54%-1.45-8.33%-0.65-48.94%-2.8-44.70%-1.91-35.42%-1.3-1.69%-0.6-429.82%-1.886.38%-1.32-5.49%-0.96-0.59
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)
Audit Opinions ----Unqualified Opinion------Unqualified Opinion------
Auditor ----Ernst & Young------Ernst & Young------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data